JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Yamamoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Yamamoto, I.

Expression of Multidrug Resistance Protein and Messenger RNA Correlate with 99mTc-MIBI Imaging in Patients with Lung Cancer

Jinshan Zhou, Kotaro Higashi, Yoshimichi Ueda, Yuko Kodama, Dachuan Guo, Fumiko Jisaki, Aya Sakurai, Tsutomu Takegami, Shogo Katsuda and Itaru Yamamoto

Departments of Radiology and Pathology and Division of Tropical Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan



View larger version (75K):

[in a new window]
 
FIGURE 1. Patient 1, 73-y-old man with 2.8 x 2.8 cm lung adenocarcinoma. (A) CT scan shows nodule in right lung. (B) Early 99mTc-MIBI SPECT scan (left) shows intense uptake (arrow) of 99mTc-MIBI in tumor (L/Ne = 3.81). Delayed scan (right) shows faint 99mTc-MIBI uptake in tumor (L/Nd = 1.00), suggesting rapid washout of 99mTc-MIBI from tumor (L/Nwr = 73.8%). Immunohistochemistry (x200) reveals strong Pgp expression (C), strong MRP expression (D), and weak LRP expression (E) in corresponding tumor tissue.

 


View larger version (90K):

[in a new window]
 
FIGURE 2. Patient 34, 68-y-old woman with 3.6 x 3.6 cm lung adenocarcinoma. (A) CT scan shows nodule in right lung. (B) Early 99mTc-MIBI SPECT scan (left) shows intense uptake of 99mTc-MIBI in tumor (L/Ne = 3.65). Delayed scan (right) also shows intense 99mTc-MIBI uptake in tumor (L/Nd = 5.17), suggesting slow washout of 99mTc-MIBI from tumor (L/Nwr = -41.6%). Immunohistochemistry (x200) reveals negative Pgp expression (C), negative MRP expression (D), and strong LRP expression (E) in corresponding tumor tissue.

 


View larger version (13K):

[in a new window]
 
FIGURE 3. Relationship between expression of Pgp, MRP, or LRP and 99mTc-MIBI L/Nd in lung cancer. (A) L/Nd correlated inversely with density of Pgp expression. Statistically significant difference in L/Nd was found between Pgp (-) group and Pgp (++) group. (B) No significant difference (n.s.) in L/Nd was found among MRP (++), MRP (+), and MRP (-) groups. (C) No significant difference in L/Nd was found among LRP (++), LRP (+), and LRP (-) groups.

 


View larger version (13K):

[in a new window]
 
FIGURE 4. Relationship between expression of Pgp, MRP, or LRP and 99mTc-MIBI L/Nwr in lung cancer. (A) L/Nwr correlated with density of Pgp expression. Statistically significant difference in L/Nwr was found between Pgp (++) group and Pgp (-) group. (B) No significant difference (n.s.) in L/Nwr was found among MRP(++), MRP (+), and MRP (-) groups. (C) No significant difference in L/Nwr was found among LRP (++), LRP (+), and LRP (-) groups.

 


View larger version (17K):

[in a new window]
 
FIGURE 5. Relationship between Pgp mRNA expression and 99mTc-MIBI L/Nd or 99mTc-MIBI L/Nwr in lung cancer. (A) L/Nd correlated inversely with Pgp mRNA level. Statistically significant difference in L/Nd was found between Pgp mRNA low-expression group and Pgp mRNA high-expression group. (B) Statistical support was found toward a significant difference in L/Nwr between Pgp mRNA high-expression group and Pgp mRNA low-expression group.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.